-
Aurobindo to buy Actavis’ operations in 7 EU nations
Aurobindo Pharma Ltd will acquire the commercial operations of Actavis…
Read more -
Biotech major Biocon has launched CANMab (biosimilar Trastuzumab) for treating breast cancer in the Indian market from next month.
Kiran Mazumdar-Shaw Net Worth $655 M As of October 2013…
Read more -
U.S. health care: A Model T in a Tesla world?
This is not sustainable. It doesn’t work for the people…
Read more -
visitation policy of UK goes for a Change!
LEXINGTON, KY. — UK HealthCare says it has amended its…
Read more -
-
Critical for survival in this era will be investment in what the pharmaceutical industry calls “limited competition drugs” and differentiated products.
The Indian pharmaceutical industry faces a crucial new year. Until…
Read more -
Govt Retains 100% FDI in Existing Pharma Units
Government today decided to retain the policy of allowing 100…
Read more -
English Babu & Desi Pharma to smile in 2014 Indian Pharma Sector
Drug major GSK may have created a flutter in the…
Read more -
26 % Growth Expected in 2014 Fiscal in Indian Pharma Sector
Sales by Indian drugmakers are set to show an average…
Read more -
FDI in India Pharma Sector
The issue of foreign direct investment in pharmaceuticals has come…
Read more